DIARY: Flu drug bugs hacks as PR lips all seem sealed
PR Week found itself going round in circles when following up the story that the National Institute of Clinical Excellence (NICE) wouldn’t recommend Glaxo Wellcome’s Relenza as an NHS drug.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>